The Mass Spectrometry society of Japan - The 68th Annual Conference on Mass Spectrometry, Japan

Abstract

Poster Presentations

Day 2, June 23(Thu.)  Room P (501, 502 and 503)

Assaying Protein / Ligand Binding with High Resolution Native Mass Spectrometry

(1Bruker Daltonik, 2PMI, 3Bruker Daltonics, 4Bruker Scientific Tech, 5SIMM)
Matthias Witt1, Marshall Bern2, Christopher Thompson3, Michael Greig3, Yongwei Wang4, K Sen2, Xuefei Yin2, Claire Bramwell2, Michelle English2, Jia Liu5, Yang Ye5, oAyako Kurimoto2

An increase in the number of candidates for drug and therapeutic candidates is happening in all pharmaceutical and research environments as mass spectrometry capabilities increase. However, the ability to process the data has not kept up. Protein Metrics has created software to automate and speed up this process to reduce the burden on scientists and to make sure that the raw data is turned into information faster.

Carbonic anhydrase (CA) catalyzes the reversible reaction
CO2 + H2O ↔ HCO3- +H+

CA is especially well suited as a model enzyme for biophysical studies of protein / ligand binding1) because it is inexpensive, well characterized, and medically relevant (in glaucoma, obesity, and altitude sickness). CA inhibitors, primarily aryl sulfonamides, are also well understood and readily available.
Here we use CA as a model enzyme for protein / ligand binding study with high resolution native mass spectrometry (nMS). There are a number of technologies for protein / ligand screening, including fluorescent or radioactive labeling, surface plasmon resonance spectroscopy, circular dichroism, and isothermal titration calorimetry.
Relative to these methods, nMS offers some advantages: no need for chemical tags, observation of multiple and nonspecific binding, and direct identification of ligands in competitive binding experiments.

Reference
1) V M. Krishnamurthy et a l., Chem Rev 2008 108(3): 946-1051